Medical Aesthetics Industry: Regulation

Jackie Doyle-Price Excerpts

Tuesday 14th May 2019 Westminster Hall

[The Parliamentary Under-Secretary of State for Health and Social Care (Jackie Doyle-Price)]

It is a pleasure to be here this afternoon during Mental Health Awareness Week, for which the theme is body image, so it is particularly appropriate that we are discussing this issue again, thanks to my hon. Friend the Member for—I can never remember.

[Alberto Costa]

South Leicestershire.

[Jackie Doyle-Price]

Thanks very much—my hon. Friend the Member for South Leicestershire (Alberto Costa). I am pleased that the all-party parliamentary group has been established since we last debated the issue in this place, and I thank the hon. Member for Swansea West—

[Carolyn Harris (Swansea East) (Lab)]

East.

[Jackie Doyle-Price]

I thank the hon. Members for Swansea East (Carolyn Harris)—I never know my east from my west—and for Bradford South (Judith Cummins) for joining that group. It is great to have the hon. Member for Falkirk (John Mc Nally) here, who obviously takes a keen interest in these matters.

[Carolyn Harris]

I apologise, Mr Owen; I tried to get here earlier. May I first congratulate the Department on today’s announcement? Our all-party parliamentary group’s inquiry is the first to assess the current regulation of non-surgical cosmetic procedures and its adequacy in ensuring customer safety. I offer the Minister the opportunity to come and to talk to us and hear the inquiry’s findings.

[Jackie Doyle-Price]

I accept that invitation most gratefully, and I look forward to hearing the conclusions. The time is right for us to take action on this, and I am grateful for the support of Members from across the House in wanting to do that and to do the right thing, with the intention of protecting consumers, which is obviously central to us, but also ensuring a system of regulation that is proportionate for the industry. We need to make sure that we balance both of those.

We have not really given the industry enough attention, given the speed with which it has grown. We increasingly see examples of consumers receiving poor treatment; my hon. Friend the Member for South Leicestershire referred to his constituent, to whom I am grateful for sharing her story. We need to make everyone much more aware of the risk because, as he says, people think it is just like having a haircut; it is becoming extremely normal to have what are poisons injected into the face. We need to make sure that everyone is aware of the risk before they undertake such a procedure, so that they can make an informed judgment.

[John Mc Nally]

I am not taking exception to the idea of it being just like having a haircut, but I have been involved in the business of hair salons for more than 50 years and have run salons, and it is not just like having a haircut. There is a similarity in terms of the investment put into any business, which is long term in some cases. When somebody comes along who has not properly trained and has little knowledge, there will be consequences of what they practise. In my all-party parliamentary group’s inquiries, we have come across modern-day slavery, trafficking, money laundering and all sorts of things, which just builds the case for a mandatory regulatory framework.

[Jackie Doyle-Price]

The hon. Gentleman makes a good point, because when we talk about these examples, there is a danger that people can apply that prejudice to the entire industry. It is in the interests of everyone involved in this industry to welcome regulation, not least to celebrate the professionalism of what they do. There are some very reputable practitioners out there who are not actually in the medical industry. For example, semi-permanent make-up—a surgical procedure that does not involve any invasion—clearly does not require as strident regulation as what we are talking about with injectables, but it is the same industry, and we need to ensure an adequate registration system.

[Judith Cummins]

I very much welcome the Minister’s announcement today. On training and regulation for beauticians—non-medical people who constitute around 50,000 jobs in the UK economy—there is huge appetite and support within the industry for proper and appropriate regulation, and there is recognition of the urgent need for that. However, there are no regulated qualifications available for non-medical practitioners for injectables at the moment. Going forward, does the Minister think there will be some kind of progression route for beauticians to go into this kind of industry, so that we can guarantee proper standards for the consumer?

[Jackie Doyle-Price]

The hon. Lady is right, and I am grateful for the spirit in which she makes her comments. Anyone who establishes themselves in business as a beautician wants to deliver a good service, has pride in what they do and would not want to be accused of doing anything unsafe.

My first focus of activity is those organisations that train people in these procedures, because I can see a situation in which a beautician will have paid thousands of pounds to go on a course and will then think that they are qualified, but they might not be. That is where we need to bring the focus of regulation in the first instance, so that when somebody proudly displays their certificates, consumers can have some guarantee that they are legitimate. I welcome the opportunity to air these issues with the all-party parliamentary group as we move this system of regulation forward.

Sadly, we only have 30 minutes for this debate, so I doubt whether I will be able to get through as much as I would wish, but I will do my best. I am grateful for the interest of all Members here. We will continue this discussion. It is worth saying that Botox treatments and dermal fillers are increasing and, along with laser hair removal, now represent nine out of 10 non-surgical treatments performed in the UK. This is a major area of risk.

Hon. Members have referenced the campaign that we launched today. Clearly, consumers will be the best defenders of their own interest, but we must make sure that they have access to appropriate information with which to do so; we need to do much more to inform people about the risk. Just as in my hon. Friend the Member for South Leicestershire’s example of his constituent, I am quite sure that many people who have had fillers—who have gone to have their lips done, like they do—would have no idea that there is a risk of their artery being injected with poison. We need to make sure that consumers are much more aware of that, which is why we are doing so much more in the next six weeks to try to raise public awareness.

We will focus on targeting our messages to women aged 18 to 34, on whom the majority of the treatments are undertaken. I am pleased that we are working with Bauer Media, which publishes Grazia, Closer and Heat, which I hope will be appropriate vehicles to reach that audience. We will make sure that the NHS information is kept up to date and remains a meaningful resource for consumers.

[Jim Shannon]

Would the Minister consider making it so that under-18s could not have this treatment?

[Albert Owen (in the Chair)]

Minister, you have less than two minutes.

[Jackie Doyle-Price]

Yes, absolutely. I am committed to bringing forward legislation to do that at the earliest possible opportunity. I would really like to engage with the all-party parliamentary group to see what other conclusions they can bring forward quickly, so that we can make use of that legislation, to strengthen the opportunities to have a meaningful register, and indeed to look at the whole issue of insurance and what we should expect everyone involved in this to do.

I am open to debate, and I am absolutely committed to bringing the age restriction in line with things like tattoos and sunbeds. Frankly, it is ridiculous that there is an age limit for getting on a sunbed but anybody can have poison injected into their face. That is clearly ridiculous, and we need to tackle it.

We will encourage consumers to look at choosing a reputable practitioner and to properly interrogate the person doing the procedure, asking them about the risks. I am pleased that Superdrug, which has moved into this field, is having pre-screening conversations with clients and giving them cooling-off time before embarking on the treatment. I think that is really good practice and is something we could encourage throughout the industry, not least because it encourages practitioners to think about how they engage with their consumers and to properly understand the risks themselves.

We are moving into a new period of regulation of dermal fillers. My hon. Friend the Member for South Leicestershire is quite right that they are completely unregulated at present, but they will become regulated by the Medicines and Healthcare Products Regulatory Agency,[Official Report, 12 June 2019, Vol. 661, c. 5MC.] which will put them on a similar footing to Botox and will mean that they need to be given by the prescriber. He is right to highlight the risk of people being able to delegate that responsibility for prescribing, and again we should look at legislating on that. Clearly we could also ask the regulators of medics to look at that, because, frankly, delegating the responsibility for prescribing does not really seem consistent with patient safety. We need to look at that.

I am fast running out of seconds, so I will conclude by thanking my hon. Friend and all hon. Members for their interest in this subject. I hope that we all continue talking about this, so that we can take action quickly. This is massive area of risk for consumers and we need to take action to fix it.

[Albert Owen (in the Chair)]

I am grateful to both the hon. Member for South Leicestershire (Alberto Costa) and the Minister for taking so many interventions.

Question put and agreed to.